Association of Rate‐Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation
Among patients on dialysis with incident AF, use of antiarrhythmic medications may be associated with lower risk of stroke and death. Future randomized trials are needed to determine the efficacy and safety of antiarrhythmic medications in this high-risk population.
Authors
- Teresa N. Harrison (ORCID: https://orcid.org/0000-0002-7827-7654)
- Dongjie Fan (ORCID: https://orcid.org/0000-0001-6321-4522)
- Daniel E. Singer (ORCID: https://orcid.org/0000-0001-6145-4848)
- Alan S. Go (ORCID: https://orcid.org/0000-0001-9109-0811)
- Leila R. Zelnick (ORCID: https://orcid.org/0000-0002-8461-5111)
- Benjamin Lidgard (ORCID: https://orcid.org/0000-0003-0484-4385)
- Nisha Bansal (ORCID: https://orcid.org/0000-0002-9583-8628)
- Ming‐Sum Lee (ORCID: https://orcid.org/0000-0001-6121-6452)
- Jaejin An (ORCID: https://orcid.org/0000-0002-3161-5732)
- Grace H. Tabada
Institutions
- Kaiser Permanente (US)
- Palo Alto University (US)
- University of California, San Francisco (US)
- University of Washington (US)
- Massachusetts General Hospital (US)
- Los Angeles Medical Center (US)
- Kaiser Permanente West Los Angeles Medical Center (US)
- Kaiser Permanente Tysons Corner Medical Center (US)
- Stanford University (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1161/jaha.124.038511
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.39